ALKERAN (melphalan) Tablets

ALKERAN Tablets are indicated for the palliative treatment of multiple myeloma and for the palliation of non-resectable epithelial carcinoma of the ovary. Brand Name: ALKERAN (melphalan) Tablets

Home | (melphalan) Tablets

ALKERAN (melphalan) Tablets Price In India and Overseas
ALKERAN (melphalan) Tablets

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

ALKERAN (melphalan) Tablets

Melphalan is approved for palliative treatment of: Multiple myeloma. Ovarian epithelial cancer that cannot be removed by surgery. Melphalan is also being studied in the treatment of other types of cancer.

ALKERAN is used to treat certain types of cancer (such as multiple myeloma, ovarian). Melphalan belongs to a class of drugs known as alkylating agents. It works by slowing or stopping the growth of cancer cells.

A drug used to treat multiple myeloma and ovarian epithelial cancer that cannot be removed by surgery. It is also being studied in the treatment of other types of cancer. Melphalan may kill cancer cells by damaging their DNA and stopping them from dividing. It is a type of alkylating agent. Also called Alkeran Tablets.

Drug (Brand / Generic): ALKERAN / melphalan
Current Indications: multiple myeloma,[8] ovarian cancer, AL amyloidosis, and occasionally malignant melanoma.
Marketed by:: ApoPharma USA In
Approval Date: 5/24/2001

Dosage forms and strengths of ALKERAN (melphalan).
tablet 2mg

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.